-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Cyclo Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2011 to 2023.
- Cyclo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$8.83M, a 85.1% decline year-over-year.
- Cyclo Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$24.8M, a 27.9% decline year-over-year.
- Cyclo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.1M, a 29.8% decline from 2022.
- Cyclo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$15.5M, a 8.15% decline from 2021.
- Cyclo Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$14.3M, a 59.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)